Cargando…
Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy
BACKGROUND: Posttreatment diffusion–weighted magnetic resonance imaging (DW‐MRI) and 18F‐fluorodeoxygluocose ((18)F‐FDG) positron emission tomography (PET) with computed tomography (PET/CT) have potential prognostic value following chemo‐radiotherapy (CRT) for head and neck squamous cell carcinoma (...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388179/ https://www.ncbi.nlm.nih.gov/pubmed/33960739 http://dx.doi.org/10.1002/cnr2.1360 |
_version_ | 1783742591576047616 |
---|---|
author | Connor, Steve Sit, Cherry Anjari, Mustafa Szyszko, Teresa Dunn, Joel Pai, Irumee Cook, Gary Goh, Vicky |
author_facet | Connor, Steve Sit, Cherry Anjari, Mustafa Szyszko, Teresa Dunn, Joel Pai, Irumee Cook, Gary Goh, Vicky |
author_sort | Connor, Steve |
collection | PubMed |
description | BACKGROUND: Posttreatment diffusion–weighted magnetic resonance imaging (DW‐MRI) and 18F‐fluorodeoxygluocose ((18)F‐FDG) positron emission tomography (PET) with computed tomography (PET/CT) have potential prognostic value following chemo‐radiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC). Correlations between these PET/CT (standardized uptake value or SUV) and DW‐MRI (apparent diffusion coefficient or ADC) parameters have only been previously explored in the pretreatment setting. AIM: To evaluate stage III and IV HNSCC at 12‐weeks post‐CRT for the correlation between SUV(max) and ADC values and their interval changes from pretreatment imaging. METHODS: Fifty‐six patients (45 male, 11 female, mean age 59.9 + − 7.38) with stage 3 and 4 HNSCC patients underwent 12‐week posttreatment DW‐MRI and (18)F‐FDG PET/CT studies in this prospective study. There were 41/56 patients in the cohort with human papilloma virus‐related oropharyngeal cancer (HPV OPC). DW‐MRI (ADC(max) and ADC(min)) and (18)F‐FDG PET/CT (SUV(max) and SUV(max) ratio to liver) parameters were measured at the site of primary tumors (n = 48) and the largest lymph nodes (n = 52). Kendall's tau evaluated the correlation between DW‐MRI and (18)F‐FDG PET/CT parameters. Mann‐Whitney test compared the post‐CRT PET/CT and DW‐MRI parameters between those participants with and without 2‐year disease‐free survival (DFS). RESULTS: There was no correlation between DW‐MRI and (18)F‐FDG PET/CT parameters on 12‐week posttreatment imaging (P = .455‐.794; tau = −0.075‐0.25) or their interval changes from pretreatment to 12‐week posttreatment imaging (P = .1‐.946; tau = −0.194‐0.044). The primary tumor ADC(mean) (P = .03) and the interval change in nodal ADC(min) (P = .05) predicted 2‐year DFS but none of the (18)F‐FDG PET/CT parameters were associated with 2‐year DFS. CONCLUSIONS: There is no correlation between the quantitative DWI‐MRI and (18)F‐FDG PET/CT parameters derived from 12‐week post‐CRT studies. These parameters may be independent biomarkers however in this HPV OPC dominant cohort, only selected ADC parameters demonstrated prognostic significance. Study was prospectively registered at http://www.controlled-trials.com/ISRCTN58327080 |
format | Online Article Text |
id | pubmed-8388179 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83881792021-08-31 Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy Connor, Steve Sit, Cherry Anjari, Mustafa Szyszko, Teresa Dunn, Joel Pai, Irumee Cook, Gary Goh, Vicky Cancer Rep (Hoboken) Original Articles BACKGROUND: Posttreatment diffusion–weighted magnetic resonance imaging (DW‐MRI) and 18F‐fluorodeoxygluocose ((18)F‐FDG) positron emission tomography (PET) with computed tomography (PET/CT) have potential prognostic value following chemo‐radiotherapy (CRT) for head and neck squamous cell carcinoma (HNSCC). Correlations between these PET/CT (standardized uptake value or SUV) and DW‐MRI (apparent diffusion coefficient or ADC) parameters have only been previously explored in the pretreatment setting. AIM: To evaluate stage III and IV HNSCC at 12‐weeks post‐CRT for the correlation between SUV(max) and ADC values and their interval changes from pretreatment imaging. METHODS: Fifty‐six patients (45 male, 11 female, mean age 59.9 + − 7.38) with stage 3 and 4 HNSCC patients underwent 12‐week posttreatment DW‐MRI and (18)F‐FDG PET/CT studies in this prospective study. There were 41/56 patients in the cohort with human papilloma virus‐related oropharyngeal cancer (HPV OPC). DW‐MRI (ADC(max) and ADC(min)) and (18)F‐FDG PET/CT (SUV(max) and SUV(max) ratio to liver) parameters were measured at the site of primary tumors (n = 48) and the largest lymph nodes (n = 52). Kendall's tau evaluated the correlation between DW‐MRI and (18)F‐FDG PET/CT parameters. Mann‐Whitney test compared the post‐CRT PET/CT and DW‐MRI parameters between those participants with and without 2‐year disease‐free survival (DFS). RESULTS: There was no correlation between DW‐MRI and (18)F‐FDG PET/CT parameters on 12‐week posttreatment imaging (P = .455‐.794; tau = −0.075‐0.25) or their interval changes from pretreatment to 12‐week posttreatment imaging (P = .1‐.946; tau = −0.194‐0.044). The primary tumor ADC(mean) (P = .03) and the interval change in nodal ADC(min) (P = .05) predicted 2‐year DFS but none of the (18)F‐FDG PET/CT parameters were associated with 2‐year DFS. CONCLUSIONS: There is no correlation between the quantitative DWI‐MRI and (18)F‐FDG PET/CT parameters derived from 12‐week post‐CRT studies. These parameters may be independent biomarkers however in this HPV OPC dominant cohort, only selected ADC parameters demonstrated prognostic significance. Study was prospectively registered at http://www.controlled-trials.com/ISRCTN58327080 John Wiley and Sons Inc. 2021-05-07 /pmc/articles/PMC8388179/ /pubmed/33960739 http://dx.doi.org/10.1002/cnr2.1360 Text en © 2021 The Authors. Cancer Reports published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Connor, Steve Sit, Cherry Anjari, Mustafa Szyszko, Teresa Dunn, Joel Pai, Irumee Cook, Gary Goh, Vicky Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy |
title | Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy |
title_full | Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy |
title_fullStr | Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy |
title_full_unstemmed | Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy |
title_short | Correlations between DW‐MRI and (18)F‐FDG PET/CT parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy |
title_sort | correlations between dw‐mri and (18)f‐fdg pet/ct parameters in head and neck squamous cell carcinoma following definitive chemo‐radiotherapy |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388179/ https://www.ncbi.nlm.nih.gov/pubmed/33960739 http://dx.doi.org/10.1002/cnr2.1360 |
work_keys_str_mv | AT connorsteve correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy AT sitcherry correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy AT anjarimustafa correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy AT szyszkoteresa correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy AT dunnjoel correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy AT paiirumee correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy AT cookgary correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy AT gohvicky correlationsbetweendwmriand18ffdgpetctparametersinheadandnecksquamouscellcarcinomafollowingdefinitivechemoradiotherapy |